Aclarion To Present at The LD Micro Main Event XV

Presentation on Tuesday, October 25th at 9:00 AM PT

Broomfield, Colorado--(Newsfile Corp. - October 12, 2022) - Aclarion, Inc.,(NASDAQ: ACON) (NASDAQ: ACONW)("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain (CLBP), announced today that it will be presenting at the 15th annual Main Event on Tuesday, October 25^th at 9:00 AM PT at the Luxe Sunset Boulevard Hotel. Executive Chairman, Jeff Thramann will be presenting an overview of the Company and providing a business update.

Event: LD Micro Main Event XV
Date: Tuesday, October 25
Time: 9:00 AM PT

Register to watch the virtual presentation here.

Summary of LD Micro Main Event XV

The 2022 LD Micro Main Event XV will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from October 25th to the 27th.

The festivities will run from 7:30 AM PT - 5:30 PM PT on the 25th and 26th, with a half day on Thursday the 27th.

This three-day, investor conference is expected to feature around 200+ companies, presenting in half-hour increments, as well as private meetings.

For more info, please contact Mr. Dean "The Dream" Summers. [email protected].

About Aclarion, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.

About LD Micro

LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies. http://www.ldmicro.com.

Investor Relations:
Kirin Smith, President
PCG Advisory, Inc.
[email protected]
www.pcgadvisory.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/140134

You May Also Be Interested In

• Apptly's UberDoc Accelerates Growth Through Emphera Health Partnership, Adding Approximately 2,000 Specialists to the UberDoc Network
• Argentina Metals Announces Closing of Acquisition of El Salado and La Quimera Properties in Mendoza, Argentina
• Harpoon Ventures Closes Oversubscribed $155 Million Fund IV to Back Founders Building Critical Technologies